Evidence map›Paper›PMID 24741107›Full record

ArticleJournal of virology2014

NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.

Célia Boukadida, Caroline Marnata, Roland Montserret, Lisette Cohen, Brigitte Blumen, Jérôme Gouttenoire, Darius Moradpour, François Penin, Annette Martin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Putative role of TMEM165 in congenital cardiomyopathies.Frontiers in molecular neuroscience · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Célia BoukadidaInstitut Pasteur, Unit of Molecular Genetics of RNA Viruses, Paris, France CNRS UMR3569, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France.
Caroline MarnataInstitut Pasteur, Unit of Molecular Genetics of RNA Viruses, Paris, France CNRS UMR3569, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France.
Roland MontserretInstitut de Biologie et Chimie des Protéines, Bases Moléculaires et Structurales des Systèmes Infectieux, Lyon, France CNRS UMR 5086, Lyon, France Labex Ecofect, University of Lyon, Lyon, France.
Lisette CohenInstitut Pasteur, Unit of Molecular Genetics of RNA Viruses, Paris, France CNRS UMR3569, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France.
Brigitte BlumenInstitut Pasteur, Unit of Molecular Genetics of RNA Viruses, Paris, France CNRS UMR3569, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France.
Jérôme GouttenoireDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Darius MoradpourDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
François PeninInstitut de Biologie et Chimie des Protéines, Bases Moléculaires et Structurales des Systèmes Infectieux, Lyon, France CNRS UMR 5086, Lyon, France Labex Ecofect, University of Lyon, Lyon, France.
Annette MartinInstitut Pasteur, Unit of Molecular Genetics of RNA Viruses, Paris, France CNRS UMR3569, Paris, France Université Paris Diderot-Sorbonne Paris Cité, Paris, France annette.martin@pasteur.fr.
Centre National de la Recherche Scientifique · FRDélégation Paris 7 · FRUniversité Claude Bernard Lyon 1 · FRUniversity Hospital of Lausanne · CHInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledGB virus B (GBV-B), which is hepatotropic in experimentally infected small New World primates, is a member of the Hepacivirus genus but phylogenetically relatively distant from hepatitis C virus (HCV). To gain insights into the role and specificity of hepaciviral nonstructural protein 2 (NS2), which is required for HCV polyprotein processing and particle morphogenesis, we investigated whether NS2 structural and functional features are conserved between HCV and GBV-B. We found that GBV-B NS2, like HCV NS2, has cysteine protease activity responsible for cleavage at the NS2/NS3 junction, and we experimentally confirmed the location of this junction within the viral polyprotein. A model for GBV-B NS2 membrane topology was experimentally established by determining the membrane association properties of NS2 segments fused to green fluorescent protein (GFP) and their nuclear magnetic resonance structures using synthetic peptides as well as by applying an N-glycosylation scanning approach. Similar glycosylation studies confirmed the HCV NS2 organization. Together, our data show that despite limited amino acid sequence similarity, GBV-B and HCV NS2 proteins share a membrane topology with 3 N-terminal transmembrane segments, which is also predicted to apply to other recently discovered hepaciviruses. Based on these data and using trans-complementation systems, we found that intragenotypic hybrid NS2 proteins with heterologous N-terminal membrane segments were able to efficiently trans-complement an assembly-deficient HCV mutant with a point mutation in the NS2 C-terminal domain, while GBV-B/HCV or intergenotypic NS2 chimeras were not. These studies indicate that virus- and genotype-specific intramolecular interactions between N- and C-terminal domains of NS2 are critically involved in HCV morphogenesis. IMPORTANCE: Nonstructural protein 2 (NS2) of hepatitis C virus (HCV) is a multifunctional protein critically involved in polyprotein processing and virion morphogenesis. To gain insights into NS2 mechanisms of action, we investigated whether NS2 structural and functional features are conserved between HCV and GB virus B (GBV-B), a phylogenetically relatively distant primate hepacivirus. We showed that GBV-B NS2, like HCV NS2, carries cysteine protease activity. We experimentally established a model for GBV-B NS2 membrane topology and demonstrated that despite limited sequence similarity, GBV-B and HCV NS2 share an organization with three N-terminal transmembrane segments. We found that the role of HCV NS2 in particle assembly is genotype specific and relies on critical interactions between its N- and C-terminal domains. This first comparative analysis of NS2 proteins from two hepaciviruses and our structural predictions of NS2 from other newly identified mammal hepaciviruses highlight conserved key features of the hepaciviral life cycle.

Indexed as

Amino Acid SequenceCell MembraneFlaviviridae InfectionsFluorescent Antibody TechniqueGB virus BHepacivirusHepatitis CHepatitis, Viral, HumanHumansImmunoblottingMolecular Sequence DataProtein ConformationSequence Homology, Amino AcidViral Nonstructural ProteinsVirus ReplicationNS2 protein, Hepatitis C virusViral Nonstructural Proteins

Identifiers

PMID24741107
PMCPMC4054453
OpenAlexW2048045379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.